Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Cue Biopharma, Inc. (NASDAQ:CUE – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 4,780,000 shares, an increase of 13.8% from the March 31st total of 4,200,000 shares. Based on an average trading volume of 256,300 shares, the short-interest ratio […]
BOSTON, April 24, 2024 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,.
Cue Biopharma (NASDAQ:CUE – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Oppenheimer in a note issued to investors on Tuesday, Benzinga reports. They currently have a $10.00 target price on the stock. Oppenheimer’s target price suggests a potential upside of 390.20% from the company’s current price. Several other research […]
Official data released over the weekend show that Chinese tourists made 119 million domestic trips during the three-day holiday, up 11.5% from the same period in 2019 before the pandemic. Domestic. -April 08, 2024 at 06:15 am EDT
- MarketScreener